Technology startups supported by Ohio Third Frontier
The Ohio Third Frontier Commission recently approved $1,100,000 in grants to support technology entrepreneurs in bringing innovative new products to the marketplace.
“From fighting invasive cancers to treating rare genetic diseases, the work that will be accomplished through the support of these awards is proof of why Ohio is the heart of innovation,” said Governor DeWine. “We’re proud to support these cutting-edge advancements and the Ohioans who are making them happen.”
“Today, we’re not only supporting Ohio’s innovators, but we’re also supporting projects that create and advance life-saving technologies for Ohioans and people across the country,” said Lydia Mihalik, director of the Ohio Department of Development and chair of the Ohio Third Frontier Commission.
The Ohio Third Frontier Technology Validation and Start-up Fund provides grants to Ohio companies aiming to license institution-owned technologies to accelerate commercialization through activities such as market research and further prototyping. This helps companies raise funds and get the licensed technology to the marketplace faster.
• BioChip Labs, Inc., located in the city of Cleveland (Cuyahoga County), was awarded $150,000 to commercialize a medical technology that aids patients by improving their red blood cell health. The technology is called The Rapid Hemoglobin-Oxygen Dissociation Assay (RHODA) and is a diagnostic tool to observe blood cell properties in individuals afflicted with red blood cell disorders and aims to improve patient outcomes. The technology was developed at Case Western Reserve University.
• Genosera, Inc., located in the city of Columbus (Franklin County), was awarded $150,000 to commercialize a new therapeutic to help treat GNE Myopathy. GNE Myopathy is a rare genetic disease that causes those afflicted to progressively lose muscle strength. The technology, called GA-001, will be used to rebuild lost muscle and eventually return the patients to their original strength. The technology was developed at the Research Institute at Nationwide Children’s Hospital.
• Kilele Health, Inc., located in the city of Dayton (Montgomery County), was awarded $150,000 to commercialize a sensor that regularly monitors heart failure patients. The technology is a button-sized sensor worn by patients to detect and monitor certain chemical indicators of heart stress. The technology was developed at the University of Cincinnati.
• Medical Interface Solutions, LLC, located in the city of Springboro (Warren County), was awarded $100,000 to commercialize a technology that boosts the accuracy of stroke detection in order to prevent inaccurate assessments. The technology is a phone app designed to help first responders detect signs of stroke, connect them with an expert stroke clinician and direct them to the closest treatment facility. The technology was developed at the University of Cincinnati.
• NeoIndicate, LLC, located in the city of Wellington (Lorain County), was awarded $150,000 to commercialize a therapeutic to help target treatment against invasive cancers by using tumor-specific imaging agents. Detecting malignant tumors relatively early allows for better treatment options for the patients. The technology uses a unique cell surface adhesion molecule fragment for diagnosing cancer. The technology was developed at Case Western Reserve University.
• Neucore Bio, Inc., located in the city of Columbus (Franklin County), was awarded $150,000 to commercialize a new therapeutic for the treatment of rare genetic disease. The company is developing technologies to enable the next generation of genetic medicine focused on combatting life-threatening diseases that typically have genetic components. The technology was developed at The Ohio State University.
• PHope, located in the city of Columbus (Franklin County), was awarded $150,000 to commercialize a medical device that helps treat cardiopulmonary diseases and respiratory failures. Their technology consists of a newly developed catheter and a complimentary septal docking station that enables patients to be moved, ambulated, and rehabbed. The technology was developed at The Ohio State University..
• Raider Technologies, LLC, located in the city of Dayton (Montgomery County), was awarded $100,000 to commercialize a new radar solution for the Advanced Air Mobility market. The technology utilizes a unique frequency diverse array radar architecture to detect and track designated targets. The technology was developed at the U.S. Air Force Research Laboratory.
The Ohio Department of Development empowers communities to succeed by investing in Ohio’s people, places and businesses. Learn more at development.ohio.gov